Statin use and the risk of colorectal cancer: A population-based case-control study
Authors:
- Hui-Fen ChiuHCHui-Fen Chiu
- Shu-Chen HoSHShu-Chen Ho
- Shang-Shyue TsaiSTShang-Shyue Tsai
- Trong-Neng WuTWTrong-Neng Wu
- Chun-Yuh YangCYChun-Yuh Yang
Open Access
- 1 January 2011
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 17 (47) , 5197-5202
Abstract
AIM: To investigate whether the use of statins is associated with colorectal cancer risk. METHODS: We conducted a population-based case-control study in Taiwan. Data were retrospectively collected from the Taiwan National Health Insurance Research Database. Cases consisted of all patients who were aged 50 years and older and had a first-time diagnosis of colorectal cancer between the period 2005 and 2008. The controls were matched to cases by age, sex, and index date. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multiple logistic regression. RESULTS: We examined 1156 colorectal cancer cases and 4624 controls. The unadjusted ORs for any statin prescription was 1.10 (95% CI = 0.94-1.30) and the adjusted OR was 1.09 (95% CI = 0.91-1.30). When statin use was categorized by cumulative dose, the adjusted ORs were 0.99 (95% CI = 0.78-1.27) for the group with cumulative statin use below 105 defined daily doses (DDDs); 1.07 (95% CI = 0.78-1.49) for the group with cumulative statin use between 106 and 298.66 DDDs; and 1.30 (95% CI = 0.96-1.75) for the group with cumulative statin use of 298.66 DDDs or more compared with nonusers. CONCLUSION: This study does not provide support for a protective effect of statins against colorectal cancer.Keywords
This publication has 41 references indexed in Scilit:
- Statins and Cancer RiskJAMA, 2006
- Cholesterol-Lowering Drugs and Colorectal Cancer Incidence in a Large United States CohortJNCI: Journal of the National Cancer Institute, 2006
- Statin use and cancer risk in the General Practice Research DatabaseBritish Journal of Cancer, 2004
- Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective StudyJournal of Women's Health, 2003
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoACirculation Research, 2002
- Statin Use and the Risk of Breast and Prostate CancerEpidemiology, 2002
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Statins Have Biphasic Effects on AngiogenesisCirculation, 2002
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of CancerArchives of internal medicine (1960), 2000
- HMG-CoA Reductase Inhibitors and the Risk of FracturesJAMA, 2000